Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Neuromodulation Devices Market: By Type: Internal Neuromodulation, External Neuromodulation; By Product: Spinal Cord Stimulators, Others; By Biomaterial; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Neuromodulation Devices Market Outlook
The global neuromodulation devices industry attained a value of USD 6 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 9% to reach USD 10 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America and Europe to Lead the Global Market
The North American region is one of the largest markets for neuromodulation devices. The reason is attributed to the higher rate of diagnosis for related diseases and their usage for chronic illness. The presence of major players in United States is also contributing to the large demand. Europe has properly developed healthcare sector with high per capita medical expenditure. The increasing approval for non-invasive devices is fueling the market demand in the region. Asia Pacific will have significant growth rate because of the rising population, economic development, and expanding healthcare infrastructure.
Neuromodulation Devices: Industry Definition and Segmentation
Neuromodulation devices are ones that act directly upon nerves by alteration of nerve activity. This is done with the help of providing the pharmaceutical or electrical agents to the desired area directly. They can be used for treatment of various diseases such as headaches, chronic pain relief, dystonia, and Parkinson’s disease.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of type, neuromodulation devices are divided into:
- Internal Neuromodulation
- External Neuromodulation
The neuromodulation devices are segmented on the basis of product into:
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Electrical Stimulation
- Transcranial Magnetic Stimulation
- Transcutaneous Electrical Nerve Stimulation Devices
- Others
On the basis of biomaterial, the industry is segmented into:
- Ceramics Biomaterials
- Metallic Biomaterials
- Polymeric Biomaterials
On the grounds of application, market is divided into:
- Pain Management
- Epilepsy
- Essential Tremors
- Urinary and Fecal Incontinence
- Depression
- Dystonia
- Parkinson’s Disease
- Others
The end use segments for neuromodulation devices are the following:
- Rehabilitation Centres
- Hospitals
- Specialty Clinics
- Others
The regional markets for custom shoes industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Applications for Neuromodulation Devices to Drive the Market
The neuromodulation devices are finding numerous applications in the healthcare sector. They are being increasingly used for chronic pain relief, epilepsy, depression, Parkinson’s disease, and other health problems. Their high efficacy in the treatment is leading to a spurt in the demand for neuromodulation devices. The major players in the market have been investing in research and development for improving the technology. This will lead to better treatment effect and more applications and hence accelerate the growth of the industry. The rise in chronic pain patients is also propelling the market demand.
Key Industry Players in the Global Neuromodulation Devices Market
The report gives a detailed analysis of the following key players in the global neuromodulation devices market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- electroCore, Inc.
- Boston Scientific Corporation
- Medtronic, plc
- Abbott Laboratories
- Synapse Biomedical Inc.
- Bioness Inc.
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Product, Biomaterial, Application, End Use, Region |
| Breakup by Type | Internal Neuromodulation, External Neuromodulation |
| Breakup by Product | Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Gastric Electrical Stimulation, Transcranial Magnetic Stimulation, Transcutaneous Electrical Nerve Stimulation Devices, Others |
| Breakup by Biomaterial | Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials |
| Breakup by Application | Pain Management, Epilepsy, Essential Tremors, Urinary and Fecal Incontinence, Depression, Dystonia, Parkinson’s Disease, Others |
| Breakup by End Use | Rehabilitation Centres, Hospitals, Specialty Clinics, Others |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | electroCore, Inc., Boston Scientific Corporation, Medtronic, plc, Abbott Laboratories, Synapse Biomedical Inc., Bioness Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Neuromodulation Devices Market Analysis
8.1 Key Industry Highlights
8.2 Global Neuromodulation Devices Historical Market (2017-2021)
8.3 Global Neuromodulation Devices Market Forecast (2022-2027)
8.4 Global Neuromodulation Devices Market by Type
8.4.1 Internal Neuromodulation
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 External Neuromodulation
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.5 Global Neuromodulation Devices Market by Product
8.5.1 Spinal Cord Stimulators
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Deep Brain Stimulators
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Vagus Nerve Stimulators
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Sacral Nerve Stimulators
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2017-2021)
8.5.4.3 Forecast Trend (2022-2027)
8.5.5 Gastric Electrical Stimulation
8.5.5.1 Market Share
8.5.5.2 Historical Trend (2017-2021)
8.5.5.3 Forecast Trend (2022-2027)
8.5.6 Transcranial Magnetic Stimulation
8.5.6.1 Market Share
8.5.6.2 Historical Trend (2017-2021)
8.5.6.3 Forecast Trend (2022-2027)
8.5.7 Transcutaneous Electrical Nerve Stimulation Devices
8.5.7.1 Market Share
8.5.7.2 Historical Trend (2017-2021)
8.5.7.3 Forecast Trend (2022-2027)
8.5.8 Others
8.6 Global Neuromodulation Devices Market by Biomaterial
8.6.1 Ceramics Biomaterials
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Metallic Biomaterials
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Polymeric Biomaterials
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.7 Global Neuromodulation Devices Market by Application
8.7.1 Pain Management
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Epilepsy
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Essential Tremors
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Urinary and Fecal Incontinence
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2017-2021)
8.7.4.3 Forecast Trend (2022-2027)
8.7.5 Depression
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2017-2021)
8.7.5.3 Forecast Trend (2022-2027)
8.7.6 Dystonia
8.7.6.1 Market Share
8.7.6.2 Historical Trend (2017-2021)
8.7.6.3 Forecast Trend (2022-2027)
8.7.7 Parkinson’s Disease
8.7.7.1 Market Share
8.7.7.2 Historical Trend (2017-2021)
8.7.7.3 Forecast Trend (2022-2027)
8.7.8 Others
8.8 Global Neuromodulation Devices Market by End Use
8.8.1 Rehabilitation Centres
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2017-2021)
8.8.1.3 Forecast Trend (2022-2027)
8.8.2 Hospitals
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2017-2021)
8.8.2.3 Forecast Trend (2022-2027)
8.8.3 Specialty Clinics
8.8.3.1 Market Share
8.8.3.2 Historical Trend (2017-2021)
8.8.3.3 Forecast Trend (2022-2027)
8.8.4 Others
8.9 Global Neuromodulation Devices Market by Region
8.9.1 Market Share
8.9.1.1 North America
8.9.1.2 Europe
8.9.1.3 Asia Pacific
8.9.1.4 Latin America
8.9.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 electroCore, Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Boston Scientific Corporation
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Medtronic, plc
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Abbott Laboratories
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Synapse Biomedical Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Bioness Inc.
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Neuromodulation Devices Market: Key Industry Highlights, 2016 and 2026
2. Global Neuromodulation Devices Historical Market: Breakup by Type (USD Million), 2017-2021
3. Global Neuromodulation Devices Market Forecast: Breakup by Type (USD Million), 2022-2027
4. Global Neuromodulation Devices Historical Market: Breakup by Product (USD Million), 2017-2021
5. Global Neuromodulation Devices Market Forecast: Breakup by Product (USD Million), 2022-2027
6. Global Neuromodulation Devices Historical Market: Breakup by Biomaterial (USD Million), 2017-2021
7. Global Neuromodulation Devices Market Forecast: Breakup by Biomaterial (USD Million), 2022-2027
8. Global Neuromodulation Devices Historical Market: Breakup by Application (USD Million), 2017-2021
9. Global Neuromodulation Devices Market Forecast: Breakup by Application (USD Million), 2022-2027
10. Global Neuromodulation Devices Historical Market: Breakup by End Use (USD Million), 2017-2021
11. Global Neuromodulation Devices Market Forecast: Breakup by End Use (USD Million), 2022-2027
12. Global Neuromodulation Devices Historical Market: Breakup by Region (USD Million), 2017-2021
13. Global Neuromodulation Devices Market Forecast: Breakup by Region (USD Million), 2022-2027
14. North America Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2017-2021
15. North America Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Europe Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2017-2021
17. Europe Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Asia Pacific Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2017-2021
19. Asia Pacific Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Latin America Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2017-2021
21. Latin America Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
22. Middle East and Africa Neuromodulation Devices Historical Market: Breakup by Country (USD Million), 2017-2021
23. Middle East and Africa Neuromodulation Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
24. Global Neuromodulation Devices Market Structure
Key Questions Answered in the Report
In 2020, the global neuromodulation devices market attained a value of nearly USD 6 billion.
The market is projected to grow at a CAGR of 9% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 10 billion by 2026.
Major industry drivers include applications in the healthcare sector, being increasingly used for chronic pain relief, epilepsy, depression, Parkinson’s disease, and other health problems.
Key industry trends include high efficacy in the treatment which is leading to a spurt in the demand and major players in the market investing in research and development for improving the technology.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America and Europe accounting for the largest share in the market.
The types of neuromodulation devices in the industry are internal neuromodulation and external neuromodulation.
Major products of the industry are spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, gastric electrical stimulation, transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation devices, among others.
The biomaterials include ceramics biomaterials, metallic biomaterials, and polymeric biomaterials.
Various application sectors of neuromodulation devices are pain management, epilepsy, essential tremors, urinary and faecal incontinence, depression, dystonia and Parkinson’s disease, among others.
The end use industries include rehabilitation centres, hospitals, and speciality clinics, among others.
The major players in the industry are electroCore, Inc., Boston Scientific Corporation, Medtronic, plc, Abbott Laboratories, Synapse Biomedical Inc. and Bioness Inc., among others.
Analyst Review
The global neuromodulation devices market attained a value of USD 6 billion in 2020, driven by the applications in the healthcare sector, being increasingly used for chronic pain relief, epilepsy, depression, Parkinson’s disease, and other health problems. Aided by the growing technological advancements, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 9%. The market is projected to reach USD 10 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the neuromodulation devices industry can be segmented into internal neuromodulation and external neuromodulation. Various application sectors of neuromodulation devices are pain management, epilepsy, essential tremors, urinary and faecal incontinence, depression, dystonia, and Parkinson’s disease, among others. Major products of the industry are spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, sacral nerve stimulators, gastric electrical stimulation, transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation devices, among others. The major regional markets for neuromodulation devices are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America and Europe accounting for the largest share of the market. The key players in the above market include electroCore, Inc., Boston Scientific Corporation, Medtronic, plc, Abbott Laboratories, Synapse Biomedical Inc. and Bioness Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global polymeric biomaterials market is driven by the rising cases of chronic cases, increasing healthcare expenditure, and rapid technological advancements in the medical sector. Aided by the gro...
The global electrosurgical devices market attained a value of USD 3130.96 million in 2021, driven by the increased demand for minimally invasive surgical procedures. Aided by the rapid technological a...
The global haemodynamic monitoring systems market attained a value of more than USD 1 billion in 2021, driven by the rising prevalence of health-related issues. Aided by the incidences of surgeries, t...
The global digital blood pressure monitor market attained a value of nearly USD 975.56 million in 2021, driven by the increasing prevalence of hypertension. Aided by the growing accuracy of wrist bloo...
The global portable ultrasound market attained a value of nearly USD 4.2 billion in 2021, driven by the rising incidences of severe illnesses across the globe and the increasing demand for efficient d...
NEWSLETTER